0001209191-22-053827.txt : 20221017 0001209191-22-053827.hdr.sgml : 20221017 20221017163602 ACCESSION NUMBER: 0001209191-22-053827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221013 FILED AS OF DATE: 20221017 DATE AS OF CHANGE: 20221017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANHARD KIMBERLY CENTRAL INDEX KEY: 0001202094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 221314061 MAIL ADDRESS: STREET 1: C/O HERON THERAPEUTICS, INC STREET 2: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-13 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001202094 MANHARD KIMBERLY 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 1 1 0 0 EVP, Drug Development Common Stock 2022-10-13 4 M 0 1250 A 15924 D Common Stock 2022-10-13 4 M 0 4564 A 20488 D Common Stock 2022-10-13 4 F 0 2012 3.76 D 18476 D Restricted Stock Units 2022-10-13 4 M 0 1250 0.00 D Common Stock 1250 10000 D Restricted Stock Units 2022-10-13 4 M 0 4564 0.00 D Common Stock 4564 37064 D Restricted stock units convert into common stock on a one-for-one basis. Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). /s/ Lisa Peraza Attorney-in-fact for Kimberly Manhard 2022-10-17